Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
[Regarding the real needs of the family of patients in Intensive Care: perception of the family and professionals].

Medicina intensiva

Abizanda R.
PMID: 17663952
Med Intensiva. 2007 Aug-Sep;31(6):271-2. doi: 10.1016/s0210-5691(07)74825-8.

No abstract available.

Cite
Abizanda R. Sobre las necesidades reales de los familiares de pacientes de Cuidados Intensivos: percepción de los familiares y del profesional. [Regarding the real needs of the family of patients in Intensive Care: perception of the family and professionals]. Med Intensiva. 2007;31(6):271-2doi: 10.1016/s0210-5691(07)74825-8.
Abizanda, R. (2007). Sobre las necesidades reales de los familiares de pacientes de Cuidados Intensivos: percepción de los familiares y del profesional. [Regarding the real needs of the family of patients in Intensive Care: perception of the family and professionals]. Medicina intensiva, 31(6), 271-2. https://doi.org/10.1016/s0210-5691(07)74825-8
Abizanda, R. "Sobre las necesidades reales de los familiares de pacientes de Cuidados Intensivos: percepción de los familiares y del profesional." [Regarding the real needs of the family of patients in Intensive Care: perception of the family and professionals]. Medicina intensiva vol. 31,6 (2007): 271-2. doi: https://doi.org/10.1016/s0210-5691(07)74825-8
Abizanda R. Sobre las necesidades reales de los familiares de pacientes de Cuidados Intensivos: percepción de los familiares y del profesional. [Regarding the real needs of the family of patients in Intensive Care: perception of the family and professionals]. Med Intensiva. 2007 Aug-Sep;31(6):271-2. doi: 10.1016/s0210-5691(07)74825-8. Spanish. PMID: 17663952.
Copy Download .nbib Format: NLM
Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice.

Journal of inflammation (London, England)

Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, López T, Casado-Nieto M, Jauquicoam C, Abizanda G, Romaguera-Ros M, Gomez-Pinedo U, Prósper F, García-Verdugo JM.
PMID: 22008614
J Inflamm (Lond). 2011 Oct 18;8(1):28. doi: 10.1186/1476-9255-8-28.

BACKGROUND: Stroke models are essential tools in experimental stroke. Although several models of stroke have been developed in a variety of animals, with the development of transgenic mice there is the need to develop a reliable and reproducible stroke...

Cite
Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, et al. Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice. J Inflamm (Lond). 2011;8(1):28doi: 10.1186/1476-9255-8-28.
Mora-Lee, S., Sirerol-Piquer, M. S., Gutiérrez-Pérez, M., López, T., Casado-Nieto, M., Jauquicoam, C., Abizanda, G., Romaguera-Ros, M., Gomez-Pinedo, U., Prósper, F., & García-Verdugo, J. M. (2011). Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice. Journal of inflammation (London, England), 8(1), 28. https://doi.org/10.1186/1476-9255-8-28
Mora-Lee, Silvia, et al. "Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice." Journal of inflammation (London, England) vol. 8,1 (2011): 28. doi: https://doi.org/10.1186/1476-9255-8-28
Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, López T, Casado-Nieto M, Jauquicoam C, Abizanda G, Romaguera-Ros M, Gomez-Pinedo U, Prósper F, García-Verdugo JM. Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice. J Inflamm (Lond). 2011 Oct 18;8(1):28. doi: 10.1186/1476-9255-8-28. PMID: 22008614; PMCID: PMC3221623.
Copy Download .nbib Format: NLM
Effect of an Exercise Intervention on Functional Decline in Very Old Patients During Acute Hospitalizations: Results of a Multicenter, Randomized Clinical Trial.

JAMA internal medicine

Martínez-Velilla N, Abizanda P, Gómez-Pavón J, Zambom-Ferraresi F, Sáez de Asteasu ML, Fiatarone Singh M, Izquierdo M.
PMID: 35040873
JAMA Intern Med. 2022 Jan 18; doi: 10.1001/jamainternmed.2021.7654. Epub 2022 Jan 18.

No abstract available.

Cite
Martínez-Velilla N, Abizanda P, Gómez-Pavón J, et al. Effect of an Exercise Intervention on Functional Decline in Very Old Patients During Acute Hospitalizations: Results of a Multicenter, Randomized Clinical Trial. JAMA Intern Med. 2022;doi: 10.1001/jamainternmed.2021.7654.
Martínez-Velilla, N., Abizanda, P., Gómez-Pavón, J., Zambom-Ferraresi, F., Sáez de Asteasu, M. L., Fiatarone Singh, M., & Izquierdo, M. (2022). Effect of an Exercise Intervention on Functional Decline in Very Old Patients During Acute Hospitalizations: Results of a Multicenter, Randomized Clinical Trial. JAMA internal medicine, . https://doi.org/10.1001/jamainternmed.2021.7654
Martínez-Velilla, Nicolás, et al. "Effect of an Exercise Intervention on Functional Decline in Very Old Patients During Acute Hospitalizations: Results of a Multicenter, Randomized Clinical Trial." JAMA internal medicine vol. (2022). doi: https://doi.org/10.1001/jamainternmed.2021.7654
Martínez-Velilla N, Abizanda P, Gómez-Pavón J, Zambom-Ferraresi F, Sáez de Asteasu ML, Fiatarone Singh M, Izquierdo M. Effect of an Exercise Intervention on Functional Decline in Very Old Patients During Acute Hospitalizations: Results of a Multicenter, Randomized Clinical Trial. JAMA Intern Med. 2022 Jan 18; doi: 10.1001/jamainternmed.2021.7654. Epub 2022 Jan 18. PMID: 35040873.
Copy Download .nbib Format: NLM
Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice.

Life (Basel, Switzerland)

Baraibar-Churio A, Bobadilla M, Machado FJD, Sáinz N, Roncal C, Abizanda G, Prósper F, Orbe J, Pérez-Ruiz A.
PMID: 34947929
Life (Basel). 2021 Dec 14;11(12). doi: 10.3390/life11121398.

Matrix metalloproteinases (MMPs) have been implicated in the progression of muscular dystrophy, and recent studies have reported the role of MMP-10 in skeletal muscle pathology of young dystrophic mice. Nevertheless, its involvement in dystrophin-deficient hearts remains unexplored. Here, we...

Cite
Baraibar-Churio A, Bobadilla M, Machado FJD, et al. Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice. Life (Basel). 2021;11(12)doi: 10.3390/life11121398.
Baraibar-Churio, A., Bobadilla, M., Machado, F. J. D., Sáinz, N., Roncal, C., Abizanda, G., Prósper, F., Orbe, J., & Pérez-Ruiz, A. (2021). Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice. Life (Basel, Switzerland), 11(12), . https://doi.org/10.3390/life11121398
Baraibar-Churio, Arantxa, et al. "Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice." Life (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/life11121398
Baraibar-Churio A, Bobadilla M, Machado FJD, Sáinz N, Roncal C, Abizanda G, Prósper F, Orbe J, Pérez-Ruiz A. Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice. Life (Basel). 2021 Dec 14;11(12). doi: 10.3390/life11121398. PMID: 34947929.
Copy Download .nbib Format: NLM
Association between Functional Assessment Instruments and Frailty in Older Adults: The FRADEA Study.

The Journal of frailty & aging

Abizanda P, Romero L, Sánchez-Jurado PM, Atienzar-Núñez P, Esquinas-Requena JL, García-Nogueras I.
PMID: 27093316
J Frailty Aging. 2012;1(4):162-8. doi: 10.14283/jfa.2012.25.

OBJECTIVES: To determine the association between functional assessment instruments and frailty.DESIGN: Concurrent cohort study.SETTING: Albacete Health Area (Spain).PARTICIPANTS: 993 subjects aged ≥ 70 years, participating in the FRADEA Study.MEASUREMENTS: The following functional instruments were applied: Barthel index, Lawton index...

Cite
Abizanda P, Romero L, Sánchez-Jurado PM, et al. Association between Functional Assessment Instruments and Frailty in Older Adults: The FRADEA Study. J Frailty Aging. 2012;1(4):162-8doi: 10.14283/jfa.2012.25.
Abizanda, P., Romero, L., Sánchez-Jurado, P. M., Atienzar-Núñez, P., Esquinas-Requena, J. L., & García-Nogueras, I. (2012). Association between Functional Assessment Instruments and Frailty in Older Adults: The FRADEA Study. The Journal of frailty & aging, 1(4), 162-8. https://doi.org/10.14283/jfa.2012.25
Abizanda, P, et al. "Association between Functional Assessment Instruments and Frailty in Older Adults: The FRADEA Study." The Journal of frailty & aging vol. 1,4 (2012): 162-8. doi: https://doi.org/10.14283/jfa.2012.25
Abizanda P, Romero L, Sánchez-Jurado PM, Atienzar-Núñez P, Esquinas-Requena JL, García-Nogueras I. Association between Functional Assessment Instruments and Frailty in Older Adults: The FRADEA Study. J Frailty Aging. 2012;1(4):162-8. doi: 10.14283/jfa.2012.25. PMID: 27093316.
Copy Download .nbib Format: NLM
Application of principal component regression to the determination of Captopril by differential pulse polarography with no prior removal of dissolved oxygen.

Talanta

Fraga JM, Abizanda AI, Moreno FJ, León JJ.
PMID: 18967129
Talanta. 1998 May;46(1):75-82. doi: 10.1016/s0039-9140(97)00254-3.

As shown in this paper, multivariate calibration in general and principal component regression (PCR) in particular allow the determination of Captopril by differential pulse polarography (DPP) in the presence of oxygen despite the overlap between their polarographic bands. Electrochemical...

Cite
Fraga JM, Abizanda AI, Moreno FJ, et al. Application of principal component regression to the determination of Captopril by differential pulse polarography with no prior removal of dissolved oxygen. Talanta. 1998;46(1):75-82doi: 10.1016/s0039-9140(97)00254-3.
Fraga, J. M., Abizanda, A. I., Moreno, F. J., & León, J. J. (1998). Application of principal component regression to the determination of Captopril by differential pulse polarography with no prior removal of dissolved oxygen. Talanta, 46(1), 75-82. https://doi.org/10.1016/s0039-9140(97)00254-3
Fraga, J M, et al. "Application of principal component regression to the determination of Captopril by differential pulse polarography with no prior removal of dissolved oxygen." Talanta vol. 46,1 (1998): 75-82. doi: https://doi.org/10.1016/s0039-9140(97)00254-3
Fraga JM, Abizanda AI, Moreno FJ, León JJ. Application of principal component regression to the determination of Captopril by differential pulse polarography with no prior removal of dissolved oxygen. Talanta. 1998 May;46(1):75-82. doi: 10.1016/s0039-9140(97)00254-3. PMID: 18967129.
Copy Download .nbib Format: NLM
Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy.

Pharmaceutics

López-Díaz de Cerio A, Perez-Estenaga I, Inoges S, Abizanda G, Gavira JJ, Larequi E, Andreu E, Rodriguez S, Gil AG, Crisostomo V, Sanchez-Margallo FM, Bermejo J, Jauregui B, Quintana L, Fernández-Avilés F, Pelacho B, Prósper F.
PMID: 34452230
Pharmaceutics. 2021 Aug 17;13(8). doi: 10.3390/pharmaceutics13081269.

The use of allogeneic adipose-derived mesenchymal stromal cells (alloADSCs) represents an attractive approach for treating myocardial infarction (MI). Furthermore, adding a natural support improves alloADSCs engraftment and survival in heart tissues, leading to a greater therapeutic effect. We aimed...

Cite
López-Díaz de Cerio A, Perez-Estenaga I, Inoges S, et al. Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics. 2021;13(8)doi: 10.3390/pharmaceutics13081269.
López-Díaz de Cerio, A., Perez-Estenaga, I., Inoges, S., Abizanda, G., Gavira, J. J., Larequi, E., Andreu, E., Rodriguez, S., Gil, A. G., Crisostomo, V., Sanchez-Margallo, F. M., Bermejo, J., Jauregui, B., Quintana, L., Fernández-Avilés, F., Pelacho, B., & Prósper, F. (2021). Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics, 13(8), . https://doi.org/10.3390/pharmaceutics13081269
López-Díaz de Cerio, Ascensión, et al. "Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy." Pharmaceutics vol. 13,8 (2021). doi: https://doi.org/10.3390/pharmaceutics13081269
López-Díaz de Cerio A, Perez-Estenaga I, Inoges S, Abizanda G, Gavira JJ, Larequi E, Andreu E, Rodriguez S, Gil AG, Crisostomo V, Sanchez-Margallo FM, Bermejo J, Jauregui B, Quintana L, Fernández-Avilés F, Pelacho B, Prósper F. Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics. 2021 Aug 17;13(8). doi: 10.3390/pharmaceutics13081269. PMID: 34452230; PMCID: PMC8399291.
Copy Download .nbib Format: NLM
Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study.

Journal of the American Geriatrics Society

Ríos SS, Zamora EBC, Céspedes AA, Rizos LR, Sánchez-Jurado PM, Sánchez-Nievas G, Romero MM, Tabernero Sahuquillo MT, Señalada JJB, Romero AM, Nogueras IG, de Dios Estrella Cazalla J, Andrés-Pretel F, Lauschke VM, Stebbing J, Abizanda P.
PMID: 34894403
J Am Geriatr Soc. 2021 Dec 11; doi: 10.1111/jgs.17620. Epub 2021 Dec 11.

BACKGROUND: There is incomplete information regarding evolution of antibody titers against SARS-CoV-2 after a two-dose strategy vaccination with BNT162b2, in older adults in long-term care facilities (LTCFs) with frailty, disability or cognitive impairment. We aimed to determine IgG antibody...

Cite
Ríos SS, Zamora EBC, Céspedes AA, et al. Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study. J Am Geriatr Soc. 2021;doi: 10.1111/jgs.17620.
Ríos, S. S., Zamora, E. B. C., Céspedes, A. A., Rizos, L. R., Sánchez-Jurado, P. M., Sánchez-Nievas, G., Romero, M. M., Tabernero Sahuquillo, M. T., Señalada, J. J. B., Romero, A. M., Nogueras, I. G., de Dios Estrella Cazalla, J., Andrés-Pretel, F., Lauschke, V. M., Stebbing, J., & Abizanda, P. (2021). Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study. Journal of the American Geriatrics Society, . https://doi.org/10.1111/jgs.17620
Ríos, Sergio Salmerón, et al. "Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study." Journal of the American Geriatrics Society vol. (2021). doi: https://doi.org/10.1111/jgs.17620
Ríos SS, Zamora EBC, Céspedes AA, Rizos LR, Sánchez-Jurado PM, Sánchez-Nievas G, Romero MM, Tabernero Sahuquillo MT, Señalada JJB, Romero AM, Nogueras IG, de Dios Estrella Cazalla J, Andrés-Pretel F, Lauschke VM, Stebbing J, Abizanda P. Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study. J Am Geriatr Soc. 2021 Dec 11; doi: 10.1111/jgs.17620. Epub 2021 Dec 11. PMID: 34894403.
Copy Download .nbib Format: NLM
Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice.

Life (Basel, Switzerland)

Baraibar-Churio A, Bobadilla M, Machado FJD, Sáinz N, Roncal C, Abizanda G, Prósper F, Orbe J, Pérez-Ruiz A.
PMID: 34947929
Life (Basel). 2021 Dec 14;11(12). doi: 10.3390/life11121398.

Matrix metalloproteinases (MMPs) have been implicated in the progression of muscular dystrophy, and recent studies have reported the role of MMP-10 in skeletal muscle pathology of young dystrophic mice. Nevertheless, its involvement in dystrophin-deficient hearts remains unexplored. Here, we...

Cite
Baraibar-Churio A, Bobadilla M, Machado FJD, et al. Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice. Life (Basel). 2021;11(12)doi: 10.3390/life11121398.
Baraibar-Churio, A., Bobadilla, M., Machado, F. J. D., Sáinz, N., Roncal, C., Abizanda, G., Prósper, F., Orbe, J., & Pérez-Ruiz, A. (2021). Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice. Life (Basel, Switzerland), 11(12), . https://doi.org/10.3390/life11121398
Baraibar-Churio, Arantxa, et al. "Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice." Life (Basel, Switzerland) vol. 11,12 (2021). doi: https://doi.org/10.3390/life11121398
Baraibar-Churio A, Bobadilla M, Machado FJD, Sáinz N, Roncal C, Abizanda G, Prósper F, Orbe J, Pérez-Ruiz A. Deficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice. Life (Basel). 2021 Dec 14;11(12). doi: 10.3390/life11121398. PMID: 34947929; PMCID: PMC8705381.
Copy Download .nbib Format: NLM
Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study.

Journal of the American Geriatrics Society

Salmerón Ríos S, Cortés Zamora EB, Avendaño Céspedes A, Romero Rizos L, Sánchez-Jurado PM, Sánchez-Nievas G, Mas Romero M, Tabernero Sahuquillo MT, Blas Señalada JJ, Murillo Romero A, García Nogueras I, Estrella Cazalla JD, Andrés-Pretel F, Lauschke VM, Stebbing J, Abizanda P.
PMID: 34894403
J Am Geriatr Soc. 2021 Dec 11; doi: 10.1111/jgs.17620. Epub 2021 Dec 11.

BACKGROUND: There is incomplete information regarding evolution of antibody titers against SARS-CoV-2 after a two-dose strategy vaccination with BNT162b2 in older adults in long-term care facilities (LTCFs) with frailty, disability, or cognitive impairment. We aimed to determine IgG antibody...

Cite
Salmerón Ríos S, Cortés Zamora EB, Avendaño Céspedes A, et al. Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study. J Am Geriatr Soc. 2021;doi: 10.1111/jgs.17620.
Salmerón Ríos, S., Cortés Zamora, E. B., Avendaño Céspedes, A., Romero Rizos, L., Sánchez-Jurado, P. M., Sánchez-Nievas, G., Mas Romero, M., Tabernero Sahuquillo, M. T., Blas Señalada, J. J., Murillo Romero, A., García Nogueras, I., Estrella Cazalla, J. D., Andrés-Pretel, F., Lauschke, V. M., Stebbing, J., & Abizanda, P. (2021). Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study. Journal of the American Geriatrics Society, . https://doi.org/10.1111/jgs.17620
Salmerón Ríos, Sergio, et al. "Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study." Journal of the American Geriatrics Society vol. (2021). doi: https://doi.org/10.1111/jgs.17620
Salmerón Ríos S, Cortés Zamora EB, Avendaño Céspedes A, Romero Rizos L, Sánchez-Jurado PM, Sánchez-Nievas G, Mas Romero M, Tabernero Sahuquillo MT, Blas Señalada JJ, Murillo Romero A, García Nogueras I, Estrella Cazalla JD, Andrés-Pretel F, Lauschke VM, Stebbing J, Abizanda P. Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study. J Am Geriatr Soc. 2021 Dec 11; doi: 10.1111/jgs.17620. Epub 2021 Dec 11. PMID: 34894403.
Copy Download .nbib Format: NLM
Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study.

Journal of the American Geriatrics Society

Ríos SS, Zamora EBC, Céspedes AA, Rizos LR, Sánchez-Jurado PM, Sánchez-Nievas G, Romero MM, Tabernero Sahuquillo MT, Señalada JJB, Romero AM, Nogueras IG, de Dios Estrella Cazalla J, Andrés-Pretel F, Lauschke VM, Stebbing J, Abizanda P.
PMID: 34894403
J Am Geriatr Soc. 2021 Dec 11; doi: 10.1111/jgs.17620. Epub 2021 Dec 11.

BACKGROUND: There is incomplete information regarding evolution of antibody titers against SARS-CoV-2 after a two-dose strategy vaccination with BNT162b2, in older adults in long-term care facilities (LTCFs) with frailty, disability or cognitive impairment. We aimed to determine IgG antibody...

Cite
Ríos SS, Zamora EBC, Céspedes AA, et al. Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study. J Am Geriatr Soc. 2021;doi: 10.1111/jgs.17620.
Ríos, S. S., Zamora, E. B. C., Céspedes, A. A., Rizos, L. R., Sánchez-Jurado, P. M., Sánchez-Nievas, G., Romero, M. M., Tabernero Sahuquillo, M. T., Señalada, J. J. B., Romero, A. M., Nogueras, I. G., de Dios Estrella Cazalla, J., Andrés-Pretel, F., Lauschke, V. M., Stebbing, J., & Abizanda, P. (2021). Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study. Journal of the American Geriatrics Society, . https://doi.org/10.1111/jgs.17620
Ríos, Sergio Salmerón, et al. "Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study." Journal of the American Geriatrics Society vol. (2021). doi: https://doi.org/10.1111/jgs.17620
Ríos SS, Zamora EBC, Céspedes AA, Rizos LR, Sánchez-Jurado PM, Sánchez-Nievas G, Romero MM, Tabernero Sahuquillo MT, Señalada JJB, Romero AM, Nogueras IG, de Dios Estrella Cazalla J, Andrés-Pretel F, Lauschke VM, Stebbing J, Abizanda P. Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study. J Am Geriatr Soc. 2021 Dec 11; doi: 10.1111/jgs.17620. Epub 2021 Dec 11. PMID: 34894403.
Copy Download .nbib Format: NLM
Synthesis and structure of new carborane-substituted cyclotriphosphazenes.

Chemistry (Weinheim an der Bergstrasse, Germany)

Abizanda D, Crespo O, Gimeno MC, Jiménez J, Laguna A.
PMID: 12866075
Chemistry. 2003 Jul 21;9(14):3310-9. doi: 10.1002/chem.200204703.

The reactions of [N(3)P(3)Cl(6)] with one, two, or three equivalents of the difunctional 1,2-closo-carborane C(2)B(10)H(10)[CH(2)OH](2) and K(2)CO(3) in acetone have been investigated. These reactions led to the new spiro-closo-carboranylphosphazenes gem-[N(3)P(3)Cl(6-2n)[(OCH(2))(2)C(2)B(10)H(10)](n)] (n=1 (1), 2 (2)) and the first fully carborane-substituted...

Cite
Abizanda D, Crespo O, Gimeno MC, et al. Synthesis and structure of new carborane-substituted cyclotriphosphazenes. Chemistry. 2003;9(14):3310-9doi: 10.1002/chem.200204703.
Abizanda, D., Crespo, O., Gimeno, M. C., Jiménez, J., & Laguna, A. (2003). Synthesis and structure of new carborane-substituted cyclotriphosphazenes. Chemistry (Weinheim an der Bergstrasse, Germany), 9(14), 3310-9. https://doi.org/10.1002/chem.200204703
Abizanda, Domingo, et al. "Synthesis and structure of new carborane-substituted cyclotriphosphazenes." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 9,14 (2003): 3310-9. doi: https://doi.org/10.1002/chem.200204703
Abizanda D, Crespo O, Gimeno MC, Jiménez J, Laguna A. Synthesis and structure of new carborane-substituted cyclotriphosphazenes. Chemistry. 2003 Jul 21;9(14):3310-9. doi: 10.1002/chem.200204703. PMID: 12866075.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries